United Therapeutics
UTHR
#1121
Rank
C$30.73 B
Marketcap
C$716.65
Share price
-2.36%
Change (1 day)
28.81%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2026 (TTM): C$40.40

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is C$40.76. In 2025 the company made an earnings per share (EPS) of C$41.96 an increase over its 2024 EPS that were of C$36.77.

EPS history for United Therapeutics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$40.40-3.72%
2025C$41.9614.1%
2024C$36.7725.59%
2023C$29.2831.54%
2022C$22.2651.18%
2021C$14.72-9.1%
2020C$16.20-581.4%
2019C-$3.36-117.79%
2018C$18.9142.11%
2017C$13.31-40.93%
2016C$22.5213.45%
2015C$19.85104.29%
2014C$9.72100.29%
2013C$4.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.82-95.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$39.24-3.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C-$2.96-107.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$10.32-74.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
C$9.13-77.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.40-86.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
C-$9.51-123.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$1.90-95.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel